UPDATE : Thursday, July 9, 2020
상단여백
Meditoxin’s future uncertain, even as final verdict nears
A recent series of development over Medytox’s botulinum toxin is making it ...
by Jeong Sae-im  |  2020-05-25 14:38
라인
Fall in new Covid-19 cases hampers developing treatment
Local drug companies are making an all-out effort to increase sites for cli...
by Jeong Sae-im  |  2020-05-22 17:31
라인
[Exclusive] Thailand recalls Medytox’s botulinum toxin
The Thai government not only suspended the sale of Meditoxin, a botulinum t...
by Jeong Sae-im  |  2020-05-21 12:33
라인
Plastic surgeons plead for mercy in nixing Meditoxin's license
Plastic surgeons and dermatologists have asked the regulator to reconsider ...
by Jeong Sae-im  |  2020-05-20 15:40
라인
‘Speed of Covid-19 vaccine development unprecedentedly fast’
With the world’s collaboration to fight the new coronavirus pandemic, resea...
by Jeong Sae-im  |  2020-05-18 17:04
라인
Medytox’s earnings plummet amid lawsuit against Daewoong
Medytox, the nation’s largest botulinum toxin maker by market share, suffer...
by Jeong Sae-im  |  2020-05-18 11:33
라인
[News Focus] Will Sanofi’s abrupt drop of diabetes study hurt commercial value of Hanmi drug?
Hanmi Pharmaceutical’s diabetes drug candidate efpeglenatide, which had led...
by Jeong Sae-im  |  2020-05-15 13:14
라인
Why did Kolon change Invossa contract manufacturer to Lonza?
Prosecutors have revealed Kolon Life Science had to change contract manufac...
by Jeong Sae-im  |  2020-05-14 12:03
라인
‘Sarpogrelate beneficial for elderly diabetic patients using antiplatelet agent’
Daewoong Pharmaceutical has said it would promote sarpogrelate, which repor...
by Jeong Sae-im  |  2020-05-12 17:32
라인
Shinpoong, Bukwang stocks jump on Covid-19 drug candidates
Shares of two Korean pharmaceutical companies have shot up since the first ...
by Jeong Sae-im  |  2020-05-11 12:03
라인
Daewoong’s BTX sales growth offset by lawsuit expenses
Daewoong Pharmaceutical earned 13.6 billion won ($11.1 million) by exportin...
by Jeong Sae-im  |  2020-05-08 12:01
라인
Cellivery sure to win licensing deal with top pharma company
“A global pharmaceutical company is conducting a verification test on thera...
by Jeong Sae-im  |  2020-05-07 11:27
라인
Anticipation for Korean BTX approval in China grows strong
The pharmaceutical industry is closely watching whether a Korean botulinum ...
by Jeong Sae-im  |  2020-05-06 11:53
라인
Korean drugmakers’ Q1 earnings rose despite Covid-19
Leading domestic pharmaceutical companies recorded robust earnings in the f...
by Jeong Sae-im  |  2020-05-01 14:45
라인
Kolon to return $12.3 million upfront payment to Mundipharma
Kolon Life Science said it would return 15 billion won ($12.3 million) upfr...
by Jeong Sae-im  |  2020-05-01 11:23
라인
Court rejects Medytox’ request to stop administrative order on BTX suspension
A local court has turned down Medytox’s appeal for suspending the execution...
by Jeong Sae-im  |  2020-04-29 17:11
라인
‘Pexa-Vec with immunotherapy reduced tumor in 75% of kidney cancer patients’
SillaJen said a combination of its oncolytic viral therapy Pexa-Vec (JX-594...
by Jeong Sae-im  |  2020-04-28 17:35
라인
Genexine’s cervical cancer DNA vaccine boosts Keytruda’s response rate
Genexine said its investigational DNA vaccine for cervical cancer has impro...
by Jeong Sae-im  |  2020-04-28 14:48
라인
Kolon begins testing gene therapy for neuropathic pain in US
Kolon Life Science said Monday it has started the administration of an expe...
by Jeong Sae-im  |  2020-04-27 16:18
라인
Reform panel tells regulator to retain consigned bioequivalence tests
The government had planned to phase out “consigned bioequivalence test syst...
by Jeong Sae-im  |  2020-04-27 13:38
여백
여백
여백
Back to Top